Published in Am J Physiol on December 01, 1997
Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J Virol (2007) 2.09
Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J Virol (2010) 1.63
The role of neutrophils during mild and severe influenza virus infections of mice. PLoS One (2011) 1.61
Involvement of the mannose receptor in infection of macrophages by influenza virus. J Virol (2000) 1.45
MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis. Am J Respir Cell Mol Biol (2009) 1.43
Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem J (2000) 1.42
Surfactant protein-D and pulmonary host defense. Respir Res (2000) 1.41
Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. J Virol (2004) 1.35
The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding. Virology (2011) 1.25
Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood (2008) 1.24
On the significance of Surfactant Protein-A within the human lungs. Diagn Pathol (2009) 1.14
Contributions of the N- and C-terminal domains of surfactant protein d to the binding, aggregation, and phagocytic uptake of bacteria. Infect Immun (2002) 1.11
Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation. J Allergy Clin Immunol (2008) 1.10
Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D. Respir Res (2007) 1.10
Binding of rat and human surfactant proteins A and D to Aspergillus fumigatus conidia. Infect Immun (1999) 1.06
Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D. Respir Res (2008) 1.04
Innate immunity to influenza virus: implications for future therapy. Expert Rev Clin Immunol (2008) 0.99
Collectins and cationic antimicrobial peptides of the respiratory epithelia. Vet Pathol (2006) 0.97
Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses. J Immunol (2012) 0.95
Distinctive anti-influenza properties of recombinant collectin 43. Biochem J (2002) 0.95
Biological activities of 'noninfectious' influenza A virus particles. Future Virol (2014) 0.95
GM-CSF modulates pulmonary resistance to influenza A infection. Antiviral Res (2011) 0.92
Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice. Respir Res (2009) 0.92
Cryptococcus neoformans is resistant to surfactant protein A mediated host defense mechanisms. PLoS One (2007) 0.92
Segmental allergen challenge alters multimeric structure and function of surfactant protein D in humans. Am J Respir Crit Care Med (2010) 0.91
Galectin-1 binds to influenza virus and ameliorates influenza virus pathogenesis. J Virol (2011) 0.90
A chemokine gene expression signature derived from meta-analysis predicts the pathogenicity of viral respiratory infections. BMC Syst Biol (2011) 0.90
Surfactant protein A genetic variants associate with severe respiratory insufficiency in pandemic influenza A virus infection. Crit Care (2014) 0.89
Inhibition of hemagglutination activity of influenza A viruses by SP-A1 and SP-A2 variants expressed in CHO cells. Med Microbiol Immunol (2007) 0.88
Virus aggregating peptide enhances the cell-mediated response to influenza virus vaccine. Vaccine (2011) 0.85
Soluble host defense lectins in innate immunity to influenza virus. J Biomed Biotechnol (2012) 0.85
Viral aggregating and opsonizing activity in collectin trimers. Am J Physiol Lung Cell Mol Physiol (2009) 0.85
Crystallographic complexes of surfactant protein A and carbohydrates reveal ligand-induced conformational change. J Biol Chem (2010) 0.85
The human side of influenza. J Leukoc Biol (2012) 0.83
Enhancement of antiviral activity of collectin trimers through cross-linking and mutagenesis of the carbohydrate recognition domain. J Innate Immun (2009) 0.83
Hapivirins and diprovirins: novel θ-defensin analogs with potent activity against influenza A virus. J Immunol (2012) 0.82
Metabolomics Investigation Reveals Metabolite Mediators Associated with Acute Lung Injury and Repair in a Murine Model of Influenza Pneumonia. Sci Rep (2016) 0.80
Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses. PLoS One (2013) 0.80
Integrated Omics and Computational Glycobiology Reveal Structural Basis for Influenza A Virus Glycan Microheterogeneity and Host Interactions. Mol Cell Proteomics (2016) 0.80
Contribution of murine innate serum inhibitors toward interference within influenza virus immune assays. Influenza Other Respir Viruses (2011) 0.80
The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development. Tob Induc Dis (2004) 0.79
The pandemic (H1N1) 2009 influenza virus is resistant to mannose-binding lectin. Virol J (2011) 0.78
Introduction of N-linked glycans in the lectin domain of surfactant protein D: impact on interactions with influenza A viruses. J Biol Chem (2011) 0.78
Mouse saliva inhibits transit of influenza virus to the lower respiratory tract by efficiently blocking influenza neuraminidase activity. J Virol (2017) 0.77
Salivary blockade protects the lower respiratory tract of mice from lethal influenza. J Virol (2017) 0.77
Sarcandra glabra Extract Reduces the Susceptibility and Severity of Influenza in Restraint-Stressed Mice. Evid Based Complement Alternat Med (2012) 0.77
A unique sugar-binding site mediates the distinct anti-influenza activity of pig surfactant protein D. J Biol Chem (2012) 0.77
A novel pathogenic mechanism of highly pathogenic avian influenza H5N1 viruses involves hemagglutinin mediated resistance to serum innate inhibitors. PLoS One (2012) 0.77
Identifying the Critical Domain of LL-37 Involved in Mediating Neutrophil Activation in the Presence of Influenza Virus: Functional and Structural Analysis. PLoS One (2015) 0.76
Bench-to-bedside review: Paediatric viral lower respiratory tract disease necessitating mechanical ventilation--should we use exogenous surfactant? Crit Care (2005) 0.75
Novel expression of a functional trimeric fragment of human SP-A with efficacy in neutralisation of RSV. Immunobiology (2016) 0.75
Severe respiratory insufficiency during pandemic H1N1 infection: prognostic value and therapeutic potential of pulmonary surfactant protein A. Crit Care (2014) 0.75
Influenza and Memory T Cells: How to Awake the Force. Vaccines (Basel) (2016) 0.75
Global and quantitative proteomic analysis of dogs infected by avian-like H3N2 canine influenza virus. Front Microbiol (2015) 0.75
Structure, genetics and function of the pulmonary associated surfactant proteins A and D: The extra-pulmonary role of these C type lectins. Ann Anat (2017) 0.75
Fatigue, alcohol and performance impairment. Nature (1997) 4.31
Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science (1999) 4.10
The binding of anti-immunoglobulin antibodies to rat thymocytes and thoracic duct lymphocytes. Eur J Immunol (1974) 3.88
A second serine protease associated with mannan-binding lectin that activates complement. Nature (1997) 3.64
Conservation. Challenges to the future conservation of the Antarctic. Science (2012) 3.01
Collectins: collagenous C-type lectins of the innate immune defense system. Immunol Today (1994) 2.81
Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial. Lancet (2000) 2.72
Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet (2001) 2.64
Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods (2000) 2.22
Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J Virol (1997) 2.18
Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J Clin Invest (1994) 2.14
Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization. Am J Pathol (1989) 2.02
The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol (1992) 1.98
Spatial and temporal operation of the Scotia Sea ecosystem: a review of large-scale links in a krill centred food web. Philos Trans R Soc Lond B Biol Sci (2007) 1.95
Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivo. Nat Biotechnol (2001) 1.91
Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a. N Engl J Med (1989) 1.85
MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity (2001) 1.84
Total immunoglobulin of rat thymocytes and thoracic duct lymphocytes. Eur J Immunol (1974) 1.84
Eggs: conveniently packaged antibodies. Methods for purification of yolk IgG. J Immunol Methods (1981) 1.83
Human mannose-binding protein functions as an opsonin for influenza A viruses. J Clin Invest (1993) 1.80
Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol (2001) 1.79
Characterization of the ethanol-inducible alc gene-expression system in Arabidopsis thaliana. Plant J (2001) 1.76
Enhanced services and stipends for foster parents: effects on retention rates and outcomes for children. Child Welfare (1992) 1.76
Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand J Immunol (1998) 1.74
BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. J Leukoc Biol (2001) 1.64
Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol (1998) 1.62
The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol (2001) 1.59
Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med (2000) 1.56
Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol (2006) 1.51
An assay for the mannan-binding lectin pathway of complement activation. J Immunol Methods (2001) 1.50
Surfactant protein-D modulates interaction of Pneumocystis carinii with alveolar macrophages. J Lab Clin Med (1995) 1.49
Isolated osteoclasts resorb the organic and inorganic components of bone. J Cell Biol (1986) 1.47
Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. Science (1987) 1.47
Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand J Immunol (2005) 1.44
Topical nitroglycerin: a potential treatment for impotence. J Urol (1989) 1.44
Endoscopic evaluation of the gastro-duodenal tolerance of short-term analgesic treatment with 25 mg diclofenac-K liquid capsules. Aliment Pharmacol Ther (2012) 1.43
Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J Immunol (1998) 1.42
Mechanism of binding of surfactant protein D to influenza A viruses: importance of binding to haemagglutinin to antiviral activity. Biochem J (2000) 1.42
Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J Invest Dermatol (1995) 1.40
Visceral mycosis in Chinook salmon (Oncorhynchus tschawytscha) due to Sporobolomyces salmonicolor. Vet Pathol (1996) 1.39
Amylase polymorphism: studies of sera and duodenal aspirates in normal individuals and in cystic fibrosis. Am J Hum Genet (1976) 1.39
Structure and homology of human C1q receptor (collectin receptor). Immunology (1993) 1.37
Passage of undegraded dietary antigen into the blood of healthy adults. Quantification, estimation of size distribution, and relation of uptake to levels of specific antibodies. Scand J Immunol (1985) 1.34
Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol (2000) 1.34
Dynamic changes in prolactin promoter activation in individual living lactotrophic cells. Endocrinology (1998) 1.34
Targeted inhibition of transcription elongation in cells mediated by triplex-forming oligonucleotides. Proc Natl Acad Sci U S A (2000) 1.32
Orbital neoplasia with enophthalmos in a cat. J Am Vet Med Assoc (1989) 1.31
Pneumocystis carinii pneumonitis: a serological study. J Clin Pathol (1979) 1.30
Apoptosis is rapidly triggered by antisense depletion of MCL-1 in differentiating U937 cells. Blood (2000) 1.29
Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J Immunol (2000) 1.28
Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose? J Virol (1998) 1.28
In vivo and in vitro antibacterial activity of conglutinin, a mammalian plasma lectin. Scand J Immunol (1990) 1.28
Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria. Blood (1999) 1.27
Detection and quantitation of immune complexes with a rapid polyethylene glycol precipitation complement consumption method (PEG-CC). Methods Enzymol (1981) 1.26
Double-blind trial of yohimbine in treatment of psychogenic impotence. Lancet (1987) 1.26
Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2. J Biol Chem (2001) 1.26
Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J Clin Invest (1995) 1.24
Intron-less RNA injected into the nucleus of Xenopus oocytes accesses a regulated translation control pathway. Nucleic Acids Res (1994) 1.24
M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement. Scand J Immunol (2005) 1.22
In vivo localisation and stability of human Mcl-1 using green fluorescent protein (GFP) fusion proteins. FEBS Lett (2000) 1.21
Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS (1993) 1.21
Resting and daily energy expenditures of free-living field voles are positively correlated but reflect extrinsic rather than intrinsic effects. Proc Natl Acad Sci U S A (2003) 1.19
Hyperadrenocorticism associated with excessive sex hormone production by an adrenocortical tumor in two dogs. J Am Vet Med Assoc (2001) 1.17
Conglutinin acts as an opsonin for influenza A viruses. J Immunol (1993) 1.17
Necropsy and histopathologic findings in 14 African hedgehogs (Atelerix albiventris): a retrospective study. J Zoo Wildl Med (1999) 1.16
Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies. Blood (1996) 1.16
Needs of hospice and clinic patients with cancer. Cancer Pract (1995) 1.15
Enhanced anti-influenza activity of a surfactant protein D and serum conglutinin fusion protein. Am J Physiol Lung Cell Mol Physiol (2000) 1.15
Site-directed mutagenesis of Cys-15 and Cys-20 of pulmonary surfactant protein D. Expression of a trimeric protein with altered anti-viral properties. J Biol Chem (1996) 1.14
Occupational sunlight exposure and melanoma in the U.S. Navy. Arch Environ Health (1991) 1.14
Generation of sensory neurons is stimulated by leukemia inhibitory factor. Proc Natl Acad Sci U S A (1991) 1.14
Neutrophil deactivation by influenza A virus. Role of hemagglutinin binding to specific sialic acid-bearing cellular proteins. J Immunol (1995) 1.13
The T lymphocyte antigen receptor--paradigm lost. Nature (1982) 1.13
Membrane-permeable luciferin esters for assay of firefly luciferase in live intact cells. Biochem J (1991) 1.13
Composition and supramolecular organization of the tectorial membrane. Laryngoscope (1987) 1.13
Synergistic interaction between alpha 2-adrenergic agonists and benzodiazepines in rats. Anesthesiology (1992) 1.12
Edible mushroom (Agaricus bisporus) lectin, which reversibly inhibits epithelial cell proliferation, blocks nuclear localization sequence-dependent nuclear protein import. J Biol Chem (1999) 1.12
Intranasal application of chitin microparticles down-regulates symptoms of allergic hypersensitivity to Dermatophagoides pteronyssinus and Aspergillus fumigatus in murine models of allergy. Clin Exp Allergy (2002) 1.10
Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL. J Immunol (2001) 1.10
Tools in the assessment of sarcopenia. Calcif Tissue Int (2013) 1.09
Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes Immun (2007) 1.08
Characterization and quantification of mouse mannan-binding lectins (MBL-A and MBL-C) and study of acute phase responses. Scand J Immunol (2001) 1.08
Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations. Clin Exp Immunol (1992) 1.08
Inherited partial trisomy 8q (22 leads to qter). Am J Dis Child (1978) 1.07
Purification and characterization of two mannan-binding lectins from mouse serum. J Immunol (2000) 1.07
Characterization of influenza A virus activation of the human neutrophil. Blood (1990) 1.07
Studies on the carbohydrate-binding characteristics of human pulmonary surfactant-associated protein A and comparison with two other collectins: mannan-binding protein and conglutinin. Biochem J (1993) 1.07
The mannan-binding-lectin pathway of the innate immune response. Curr Opin Immunol (2001) 1.06
Degradation of native type IV procollagen by human neutrophil elastase. Implications for leukocyte-mediated degradation of basement membranes. Biochemistry (1987) 1.06
Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera. Clin Exp Immunol (1983) 1.06
Passage of undegraded dietary antigen into the blood of healthy adults. Further characterization of the kinetics of uptake and the size distribution of the antigen. Scand J Immunol (1986) 1.06
A simple and reliable method for the drying of polyacrylamide slab gels. J Biochem Biophys Methods (1982) 1.06
Involvement of MAP kinase in insulin signalling revealed by non-invasive imaging of luciferase gene expression in single living cells. Curr Biol (1995) 1.05
Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs. Gut (1997) 1.05
Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J Immunol (1999) 1.05